Ipilimumab Biosimilar - Research Grade
Product Specifications
Background
Product Name Alternative
Ctla4, Cytotoxic T-lymphocyte protein 4, CD152
UniProt
P16410
Host
Humanized
Reactivity
Human
Target
CTLA-4
Isotype
IgG1 κ
Sequence
https://www.imgt.org/mAb-DB/
Purification Method
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Concentration
1.0 - 5.0 mg/mL
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>95% by SDS-PAGE and HPLC
Buffer
ICH3001-100ml ICH3002-100ml ICH3003-100ml
Shipping Conditions
Blue ice
Storage Conditions
Product Datasheet
https://ichor.bio/productpdf/print/index/url_key/ipilimumab-biosimilar-research-grade/
Specificity
Detects human CTLA-4. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Ipilimumab.
Formulation
Phosphate buffered saline (PBS) pH 7.2, with no carrier protein, potassium or preservatives added. BSA and Azide free.
Isotype Control
Bulk Human IgG1 Isotype Control (IB1) [ICH2254]
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items